Read all about our recent news and clinical studies from the Clearblue Healthcare Professional Team

 

 

Women’s experiences of ovulation testing: a qualitative analysis

08/02/2016

Reproductive Health Journal

This new publication summarises exit interviews conducted on women who participated in a randomised controlled trial observing levels of stress while trying to conceive. The telephone interviews sought to gain feedback on women’s experiences of using the Clearblue Digital Ovulation Test.

You can download the publication here


 

2016 Congress Diary

01/01/2016

Our 2016 Congress Diary has been added. Please click here for details on a range of international and local congresses in the field of Obstetrics, Gynecology and Reproductive Health.

See 2016 Congress Diary


 

2015 Congress Diary

08/01/2015

Our 2015 Congress Diary has now been added. Please click here for details on a range of Local and International Congresses in the field of Obstetrics, Gynecology and Reproductive Health.

See 2015 Congress Diary


 

ESHRE 2014 Annual Meeting, Munich

05/05/2014

June 29th – July 2nd
ESHRE 2014 Annual Meeting, Munich
Stand E50 at the International Congress Centre Munich

Come & meet us to:
·        Talk about our exciting NEW Clearblue Advanced Fertility Monitor
·        Pick up a copy of our latest publications
·        See demonstrations of our pregnancy, ovulation and fertility test range
 
We look forward to welcoming you to our stand!


 

Visit Clearblue at ACOG

22/04/2014

April 28-30th, Chicago
McCormick Place Convention Centre,
Stand #837 at the 2014 ACOG Annual Clinical Meeting

Come & meet us to:
·        Talk about our exciting NEW pregnancy test products
·        Pick up a copy of our latest publications
·        See demonstrations of our pregnancy, ovulation and fertility test range
 
We look forward to welcoming you to our stand!


 

Clearblue Fertility and Ovulation tests are different and work in different ways

06/03/2014

Find out more about the products and how they differ. This chart will help you to support your patients in finding the right product for them.

Compare Now


 

British Fertility Society Annual Meeting 2014

26/11/2013

January 8th-9th, Sheffield, UK
The Mercure Hotel, Sheffield

Clearblue will be attending BFS Annual Meeting. Come and talk to us about the launch of our new Clearblue Digital Ovulation Test with Dual Hormone Indicator which identifies a wider fertile window than any other ovulation test for more opportunities to get pregnant naturally. We look forward to welcoming you to our stand.


 

Visit Clearblue at the Association of Early Pregnancy Units (AEPU) Annual Conference

30/10/2013

AEPU 2013

October 14-15, Leeds, UK
The Marriott Hotel

Come and talk to us about the launch of our new Clearblue Digital Ovulation Test with Dual Hormone Indicator which identifies a wider fertile window than any other ovulation test for more opportunities to get pregnant naturally


 

Detection of two urinary hormones by a new home ovulation test to identify the wider fertile window: a randomised comparative laboratory study of home ovulation tests

03/07/2013

A new home ovulation test (Clearblue Dual-Hormone Digital Test) detects both the pre-ovular urinary rise in estrone-3-glucuronide (E3G) and luteinising hormone (LH). The device aims to identify a wider fertile period than other home ovulation tests. This study examines the number of fertile days detected by a variety of home ovulation tests. Click here to view the poster presented at ESHRE’s 29th Annual Meeting (London, 2013).


 

Stress and Ovulation Tests

05/03/2013

Results of a recent study conducted by Clearblue showed that using a test such as the Clearblue Digital Ovulation Test does not add to the stress levels of women trying to conceive. In fact, it can bring benefits to the process. In the study, published in the prestigious journal, Human Reproduction, women using digital ovulation tests to time intercourse were found to be no different in terms of stress levels than women who were trying to conceive using the NICE clinical guidelines that recommend intercourse every 2 days. Moreover, use of digital ovulation tests was seen as offering additional benefits, including an increased understanding of the individual’s menstrual cycle. This was shown to give these women reassurance and confidence in focusing conception attempts at the most optimum time in their cycle. Click here to read the full study.

Link to more